samedan logo
 
 
 
spacer
home > pmps > summer 2007 > intuitive packaging
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Intuitive Packaging

Hans-Erik Gording at Bang & Olufsen Medicom asks, can medical device enhancement of packaging really improve patient outcomes?

“Drugs don’t work in patients who don’t take them.” This well known quotation from former US Surgeon General C Everett Coop may state the obvious, but the impact and consequences of noncompliance are both widespread and far reaching. The WHO report on adherence to long-term treatments, published in 2003, showed that approximately half of all medications prescribed for chronic illnesses, such as hypertension or hypercholesterolemia, was not taken appropriately. This has a huge impact on all stakeholders, be it the patient, the healthcare providers or society as a whole.

WHAT IS PATIENT COMPLIANCE?

Drug regime compliance is defined as the degree of correspondence between actual dosing history and the prescribed regimen. This means that the administration-intake of a correct dose of the drug must take place at a defined time (compliance), and that the patient will continue doing so for the whole period of treatment (persistence). Typically, patients will accommodate dosing intake time within their routine, and can frequently forget to take medication.

COMPLIANCE MONITORING

Compliance monitoring is an important factor in both clinical trials and everyday intake of medication. However, clinical papers report an alarming discrepancy between patient reported and actual medication compliance and, as such, electronic monitoring of patient compliance is widely accepted as the gold standard (1), although it is frequently not applied in clinical trials. Good knowledge and improvement of patient compliance can have a significant effect on patient outcomes in clinical trials. In addition, higher compliance rates can significantly reduce the required sample size, number of study sites and, potentially, the duration of clinical studies from first patient in to last patient out. The following methods are used in monitoring patient compliance.

Compliance monitoring is an important factor in both clinical trials and everyday intake of medication. However, clinical papers report an alarming discrepancy between patient reported and actual medication compliance and, as such, electronic monitoring of patient compliance is widely accepted as the gold standard (1), although it is frequently not applied in clinical trials. Good knowledge and improvement of patient compliance can have a significant effect on patient outcomes in clinical trials. In addition, higher compliance rates can significantly reduce the required sample size, number of study sites and, potentially, the duration of clinical studies from first patient in to last patient out. The following methods are used in monitoring patient compliance.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Hans-Erik Gording is an International Key Account Manager at Bang & Olufsen Medicom, an associated medical device technology company of the Danish audio visual group Bang & Olufsen. Hans-Erik joined Bang & Olufsen Medicom in 2005, following 10 years of experience within the pharmaceutical industry working within sales, training, key opinion leader development and business development roles.
spacer
Hans-Erik Gording
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Safe’n’Spray: A Winner at CPhI Festival of Pharma

Nemera’s concept device Safe'n'SprayTM was rewarded under the category 'Excellence in Pharma - Drug Delivery Devices'
More info >>

White Papers

Conveying Medical Guidance in Clinical Trials – A Survey

Europital Medical Consultancy

With the incremental demand for proactive safety surveillance throughout the conduct of clinical trials, the role of Medical Management is at the fore in ensuring the safety and wellbeing of the participants. The complex responsibilities of a Medical Monitor (MM) starts from the design and development phase, through to study close out. Understanding the principle behind the protocol and the prospective medical solution the study would deliver forms the bloodline for the MM role. Often, the MM is the face of contact for both the site personnel and the study team members with regard to medical, safety and scientific issues within the project. When it comes to medical guidance, the communication channel used to deliver solutions contributes to a large extent in effectively managing decisive situations. Our previous study on acquiring medical guidance from an operations team perspective revealed that e-mails were the most used communication method (see the article, 'Talking Points', in ICT November 2014). In our efforts to further strengthen the mode of medical guidance delivery, we designed a survey to study the existing trend and constraints in this communication chain management, as outlined here.
More info >>

 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement